Insilico Medicine
Kelly Qiao is a Senior Principal at B Capital, a position held since February 2021. Qiao also serves as an Investor and Observer at MacroLux Medical Technology Co., Ltd., Spectrumedics International, Grit Biotechnology, AlphaLife Sciences, ProfoundBio, and as an Investor at Beijing Yuanxin Technology Co., Ltd. and 镁信健康. With extensive experience in investment roles, Qiao's educational background includes a PhD in Biology and a Bachelor's degree in Chemistry from Tsinghua University, along with an MBA in Finance from The Chinese University of Hong Kong.
This person is not in any teams
This person is not in any offices